120 related articles for article (PubMed ID: 2787406)
1. Lung derived surface active material (SAM) inhibits natural killer cell tumor cytotoxicity.
Baughman RP; Strohofer S
J Clin Lab Immunol; 1989 Feb; 28(2):51-4. PubMed ID: 2787406
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of macrophage and monocyte cytotoxicity by the surface active material of lung lining fluid.
Baughman RP; Mangels DJ; Strohofer S; Corser BC
J Lab Clin Med; 1987 Jun; 109(6):692-7. PubMed ID: 3585142
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.
Dadmarz R; Bockstoce DC; Golub SH
Lymphokine Cytokine Res; 1994 Dec; 13(6):349-57. PubMed ID: 7535569
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of natural, interleukin-2 stimulated and bacillus Calmette-Guerin enhanced cytotoxicity with anti-CD16 antibodies.
Kaasinen ES; Harju LM; Timonen TT
J Urol; 2002 May; 167(5):2209-14. PubMed ID: 11956480
[TBL] [Abstract][Full Text] [Related]
5. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
[TBL] [Abstract][Full Text] [Related]
6. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
[TBL] [Abstract][Full Text] [Related]
7. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
Lanier LL; Benike CJ; Phillips JH; Engleman EG
J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
[TBL] [Abstract][Full Text] [Related]
8. Natural killer activity is present in rat lung lavage and inhibited by lidocaine.
Renzi PM; Ginns LC
Immunopharmacol Immunotoxicol; 1990; 12(3):389-415. PubMed ID: 2266229
[TBL] [Abstract][Full Text] [Related]
9. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
Burns GF; Triglia T; Werkmeister JA
J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
[TBL] [Abstract][Full Text] [Related]
10. [Inhibition of natural killer and interleukin 2-activated natural killer cell cytotoxicity by monosaccharides and lectins].
Imir T; Bankhurst AD
Mikrobiyol Bul; 1987 Oct; 21(4):245-50. PubMed ID: 3509759
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive activity of peritoneal fluid in women with endometriosis.
Oosterlynck DJ; Meuleman C; Waer M; Koninckx PR; Vandeputte M
Obstet Gynecol; 1993 Aug; 82(2):206-12. PubMed ID: 8336865
[TBL] [Abstract][Full Text] [Related]
12. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
13. Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.
von Lilienfeld-Toal M; Nattermann J; Feldmann G; Sievers E; Frank S; Strehl J; Schmidt-Wolf IG
Clin Exp Immunol; 2006 Jun; 144(3):528-33. PubMed ID: 16734623
[TBL] [Abstract][Full Text] [Related]
14. The selective growth of murine newborn-derived suppressor cells and their probable mode of action.
Jadus MR; Parkman R
J Immunol; 1986 Feb; 136(3):783-92. PubMed ID: 2934478
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lymphokine-activated killer cell function by human alveolar macrophages.
Roth MD; Golub SH
Cancer Res; 1989 Sep; 49(17):4690-5. PubMed ID: 2788029
[TBL] [Abstract][Full Text] [Related]
16. In vivo augmentation of rat lung natural killer cell activity and inhibition of experimental metastases by double-stranded polynucleotides.
Nolibe D; Aumaitre E; Thang MN
Cancer Res; 1985 Oct; 45(10):4774-8. PubMed ID: 4027965
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of natural killer cell activity by lipopolysaccharide through separable effects on the binding of nonadherent lymphocytes to tumor targets and tumor killing.
Salata RA; Kleinhenz ME; Schacter BZ; Ellner JJ
Cancer Res; 1984 Mar; 44(3):1044-7. PubMed ID: 6607107
[TBL] [Abstract][Full Text] [Related]
18. The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.
Mulé JJ; Yang J; Shu S; Rosenberg SA
J Immunol; 1986 May; 136(10):3899-909. PubMed ID: 2871106
[TBL] [Abstract][Full Text] [Related]
19. Effects of transforming growth factor-beta on human lymphokine-activated killer cell precursors. Autocrine inhibition of cellular proliferation and differentiation to immune killer cells.
Kasid A; Bell GI; Director EP
J Immunol; 1988 Jul; 141(2):690-8. PubMed ID: 3133414
[TBL] [Abstract][Full Text] [Related]
20. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
